CTTI Project: Developing Novel Endpoints, Planning Decentralized Trials
Today the Clinical Trials Transformation Initiative (CTTI) announced a new online Digital Health Trials Hub featuring enhanced recommendations and additional resources.
CTTI Project: Developing Novel Endpoints, Planning Decentralized Trials
Today the Clinical Trials Transformation Initiative (CTTI) announced a new online Digital Health Trials Hub featuring enhanced recommendations and additional resources.
[yoast-breadcrumb]
CTTI Project: Supporting Decentralized Trial Approaches
The Clinical Trials Transformation Initiative (CTTI) will unveil new recommendations to speed the use of decentralized clinical trials (DCTs)—trials run through telemedicine and mobile health care providers—today at the DPharm: Disruptive Innovations to Advance Clinical Trials conference in Boston, Mass.
Download Press Release (267.49 KB)
[yoast-breadcrumb]
CTTI Project: Supporting Decentralized Trial Approaches
A collaborative research team established by the Clinical Trials Transformation Initiative (CTTI) created a new tool and recommendations to improve the efficiency and quality of multi-center clinical trials.
Download Press Release (52.81 KB)
JULY 11, 2017 TO JULY 12, 2017
CTTI Project: Supporting Decentralized Trial Approaches
Meeting Objectives
Sheraton Silver Spring Hotel 8777 Georgia Ave, Silver Spring, MD
The views and opinions expressed in this presentation are those of the individual presenter and should not be attributed to the Clinical Trials Transformation Initiative, or any organization with which the presenter is employed or affiliated.
AUGUST 25, 2021 TO AUGUST 26, 2021
CTTI Project: Supporting Decentralized Trial Approaches
In order to update CTTI’s existing decentralized clinical trials (DCT)* recommendations, this expert meeting aimed to:
*For the purposes of this meeting, DCTs were defined as those executed through telemedicine and mobile/local healthcare providers, using procedures that vary from the traditional clinical trial model (e.g., the investigational medical product is shipped directly to the trial participant).
Virtual Meeting
The views and opinions expressed in these presentations are those of the individual presenter and should not be attributed to the Clinical Trials Transformation Initiative, or any organization with which the presenter is employed or affiliated.
CTTI Project: Preparing a Site
CTTI Project: Developing Novel Endpoints and Planning Decentralized Trials
CTTI Project: Supporting Decentralized Trial Approaches
CTTI Project: Clinical Trials Issues Related to COVID-19
Despite widespread support for decentralization, real and perceived challenges remain, limiting wider implementation of decentralized elements. A new CTTI publication, published in the Journal of Therapeutic Innovation & Regulatory Science, explores three perceptions that are commonly heard as barriers to the adoption of decentralized approaches in clinical trials. Because the integration of these approaches has the potential to enhance accessibility, diversity, and to reduce the burden on participants and caregivers, it is crucial to understand which barriers can be readily addressed with existing strategies.
In this commentary, CTTI staff outline the three barriers to adoption, discuss the degree to which the perceived and real barriers can be overcome, and share existing resources sponsors and trial designers can use to address them.